NTR · Nutrien Ltd. · Financials
Market Cap
$34.47B
Shares
477.21M
Volume · Sep 30
1.73M
Avg daily vol (3M)
2.66M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$26.89B
+3.5%
FY2025
Net Income
$2.27B
+236.4%
FY2025
Gross Margin
31.05%
+2.1pp
FY2025
Operating Margin
13.9%
+6.8pp
FY2025
Diluted EPS
$4.66
+242.6%
FY2025
Operating Cash Flow
$4.01B
+13.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| $26.89B | $25.97B | $29.06B | $37.88B | $27.71B | $20.91B | $20.08B | $19.64B | $4.55B | |
| $17.6B | $17.49B | $19.61B | $21.59B | $17.45B | $14.81B | $13.81B | $13.38B | $3.32B | |
| $8.35B | $7.53B | $8.47B | $15.42B | $9.41B | $5.24B | $5.5B | $5.39B | $694M | |
| 31.05% | 28.99% | 29.16% | 40.71% | 33.95% | 25.06% | 27.39% | 27.46% | 15.26% | |
| $600M | $644M | $626M | $565M | $477M | $429M | $404M | $423M | $185M | |
| $2.37B | $2.34B | $2.17B | $2.01B | $1.95B | $1.99B | -$1.8B | -$1.59B | -$692M | |
| $3.74B | $1.86B | $2.75B | $10.81B | $4.78B | $902M | $1.86B | $414M | $209M | |
| 13.9% | 7.15% | 9.45% | 28.53% | 17.25% | 4.31% | 9.27% | 2.11% | 4.6% | |
| $6.11B | $4.2B | $4.91B | $12.82B | $6.73B | $2.89B | $63M | -$1.18B | -$483M | |
| $687M | $720M | $793M | $563M | $613M | $520M | $554M | $538M | $238M | |
| $3.05B | $1.14B | $1.95B | $10.25B | $4.17B | $382M | $1.31B | -$124M | -$29M | |
| $752M | $436M | $670M | $2.56B | $989M | -$77M | $316M | -$93M | -$183M | |
| $2.27B | $674M | $1.26B | $7.66B | $3.15B | $459M | $992M | $3.57B | $327M | |
| 8.43% | 2.6% | 4.33% | 20.22% | 11.38% | 2.2% | 4.94% | 18.2% | 7.19% | |
| USD/shares | $4.66 | $1.36 | $2.53 | $14.22 | $5.53 | $0.81 | $1.70 | $5.72 | $0.39 |
| USD/shares | $4.66 | $1.36 | $2.53 | $14.18 | $5.52 | $0.81G | $1.70 | $5.72 | $0.39 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2017–FY2025: $11.23B in buybacks, $8.56B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.
Key facts
CIK
1725964
CUSIP
67077M108
13F (30d)
15 filings
13 filers
Visit website
Investor relations